Cello Health

Cello Health are a passionate team of global advisers, expert at navigating life science clients to confident critical decisions

Join our team

We are always on the lookout for great people who want to do things on the cutting edge of science and technology

Join us

Teams of experts

We are expert navigators helping guide our clients to more successful outcomes

Our people

With a global perspective

We work with 24 of the top 25 pharmaceutical companies as well as 100s of biotechs globally from our offices in the US and Europe

Our locations

Giving back

We support a variety of causes across our global business

Giving back

We provide multiple perspectives, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices

We recognize that the journey is often as important as the destination. We work like an extension of your team so your overall journey with us feels better

How we work What we do
We provide multiple perspectives, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices

Share our fresh thinking >

Asset and Brand planning – what do we do differently when the future has shifted?
Asset and Brand planning – what do we do differently when the future has shifted?
With much talk of a changed pharma and biotech market landscape, we ask Jon Bircher, Chief Commercial Officer of Cello Health, and Carl Engleman, Vice President at Cello Health Consulting, for their thoughts on tackling the challenges of asset and brand planning against the backdrop of such an uncertain future.
When the Wheels fall off the Brand Planning Cycle
When the Wheels fall off the Brand Planning Cycle
COVID-19 is disrupting working life as we all know it. In the context of the annual brand planning cycle, we caught up with Jane Ayton and Peter Smith, two of our Senior Vice Presidents at Cello Health Consulting, to get their view of the challenges ahead.
Harnessing Collective Social Identity in COVID-19
Harnessing Collective Social Identity in COVID-19
Countries around the world have had to impose strict restrictions on people’s normal daily lives and impose emergency measures to contain coronavirus.
BioPharma Deal-Making in the Time of Social Distancing
BioPharma Deal-Making in the Time of Social Distancing
Mutual trust is required to ink long-term collaborative deals, and that trust is best built over time and through recurrent face-to-face personal interactions.
More Fresh Thinking

Let’s work together

The journey to scientific and commercial success is often complex and always critical. If you are looking for an expert partner to help steer you to confident solutions, contact us today

Contact us